The Jab from Economist Radio

By The Economist

News & Politics Science & Medicine

What's The Jab from Economist Radio about?

The Economist unlocks the science, data and politics behind the most ambitious inoculation programme the world has ever seen.
Alok Jha, The Economist’s science correspondent, hosts with Natasha Loder, our health-policy editor. Each week our reporters and data journalists join them in conversation, along with scientists around the world. They inject the perfect dose of insight and analysis into the global effort to escape the pandemic. 

Download our free app to listen on your phone

LAST EPISODE

The Jab: How to persuade th...

04.12.2021

All adults in America are now eligible for a covid-19 vaccine. Around 30% of those polled in the country, however, are hesitant to take the jab. A shortage of vaccines will soon become a shortage of arms. What is the ...

The Jab from Economist Radio episodes:

04.12.2021 The Jab: How to persuade the sceptics? All adults in America are now eligible for a covid-19 vaccine. Around 30% of those polled in the country, however, are hesitant to take the jab. A shortage of vaccines will soon become a shortage of arms. What is the ...
04.05.2021 The Jab: Can distribution be fair? More than a billion doses of covid-19 vaccine have been made. Now comes the hard part: ensuring every country in the world has access to them. Can distribution be made more equitable? Alok Jha and Natasha Loder are joined by ...
03.29.2021 The Jab: How will science benefit? The concerted and rapid efforts to counter covid-19 have turbo-charged scientific progress. How can this new knowledge be applied to treat future threats to human health? Gregg Glenn, head of research and development at Novavax on why that vaccine is ...
03.22.2021 The Jab: Will America do better than Europe? The EU was slow to roll out covid-19 vaccines, then destroyed confidence in the Astrazeneca vaccine and is now embroiled in a row over supplies. Will America avoid Europe's pitfalls? Dr Anthony Fauci, chief medical adviser to President Biden, explains ...
03.15.2021 The Jab: How will behaviour change? The world has stumbled through the pandemic by nationalising risk. In heavily infected countries citizens have been ordered to stay home for weeks at a time. As covid-19 vaccination programmes spread, governments must gradually restore choice to the individual. How? ...
03.08.2021 The Jab: Trial and error? Large scale covid-19 vaccine trials have taken place at exceptional speed with unprecedented scrutiny. How do they work? And why are the results so politically charged? We speak to Andrew Catchpole, lead scientist on the first trial to infect volunteers ...
03.01.2021 The Jab: Will there be enough vaccines? It is one thing to design and test covid-19 vaccines. It is another to make them at sufficient scale to generate the billions of doses needed to vaccinate the world’s population. How are the vaccines produced, why is production so ...
02.22.2021 The Jab: Are the vaccines effective enough? Three vaccines have been approved by stringent regulators. Ten are being used in one or more countries. How do they work and are they effective enough against new variants of the coronavirus? Sarah Gilbert, inventor of the Oxford/Astrazeneca vaccine, tells ...
02.15.2021 The Jab: How well will vaccines work? The race between infections and injections is in its most crucial phase. What life is like on the other side of the pandemic depends on three things: how well vaccines work, whether there are enough and how many people take ...
02.08.2021 The Jab: Trailer In this new weekly podcast series, The Economist unlocks the science, data and politics behind the most ambitious inoculation programme the world has ever seen. Alok Jha, The Economist’s science correspondent, hosts with Natasha Loder, our health policy editor. Each ...